Starting on June 27, 2026, older Americans will be able to access GLP-1 medications for weight loss under Medicare. This marks a significant development in healthcare options for this demographic.
GLP-1s are a class of medications that have shown effectiveness in aiding weight loss. Their inclusion in Medicare coverage could provide new avenues for older adults seeking to manage their weight.
As this change approaches, it is essential for eligible beneficiaries to understand the implications and benefits of this new coverage under Medicare.